NEW YORK (GenomeWeb News) - Qiagen yesterday said second-quarter revenue rose 19 percent as R&D spending increased 25 percent and net income rose nearly 60 percent.
 
Financial results for the quarter did not include any contribution from Digene, which Qiagen purchased in a $1.6 billion deal that closed on July 31.
 
Total receipts for the three months ended June 30 rose to $135 million from $113.2 million year over year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Congress approved a bill Friday that would increase the US National Institutes of Health's funding by $2 billion for fiscal year 2019.

UK's Labour Party calls for a ban on non-invasive prenatal testing for determining sex, BBC News reports.

Sarah Lawrence College's Laura Hercher warns in a New York Times op-ed that more people are going to need help figuring out what their consumer genetic testing results mean.

In PLOS this week: intra-tumor heterogeneity patterns, genomic analysis of Thoroughbred horse origins, and more.